株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

心房細動:技術と世界市場

Atrial Fibrillation: Technologies and Global Markets

発行 BCC Research 商品コード 733538
出版日 ページ情報 英文 120 Pages
即納可能
価格
本日の銀行送金レート: 1USD=112.99円で換算しております。
Back to Top
心房細動:技術と世界市場 Atrial Fibrillation: Technologies and Global Markets
出版日: 2018年10月23日 ページ情報: 英文 120 Pages
概要

世界の心房細動装置市場は、2018年の41億米ドルから2023年までに78億米ドルへ達すると予測され、この間は13.6%のCAGR (年間複合成長率) が見込まれています。

当レポートでは、世界の心房細動装置市場について調査し、市場および技術の概要、市場動向とデータ実績・予測、薬物療法・外科的介入・その他の様相の詳細な説明、様々な政府規制の考察、および主要企業のプロファイルなどを提供しています。

第1章 イントロダクション

第2章 サマリー・ハイライト

第3章 背景

  • 心臓の構造・機能
  • 心不整脈
  • 心房細動 (AFib)
  • 現在の心房細動治療の基準

第4章 市場概要

  • 市場ダイナミクス
  • 規制情勢

第5章 市場分析:装置のタイプ別

  • イントロダクション・世界市場
  • カテーテルアブレーション装置
  • 左心耳 (LAA) 遮断装置

第6章 市場分析:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋
  • その他

第7章 競合情勢・近年の発展

  • 市場シェア分析
  • 参入障壁
  • 製品ポートフォリオ分析
  • 近年の主なイベント

第8章 企業プロファイル

  • ABBOTT LABORATORIES
  • ABLACOR MEDICAL CORP.
  • ACUTUS MEDICAL INC
  • AEGIS MEDICAL INNOVATIONS
  • AFREEZE GMBH
  • AURIS HEALTH (HANSEN MEDICAL)
  • ATRICURE INC
  • BIOTRONIK
  • BOSTON SCIENTIFIC
  • CARDIOFOCUS
  • CATHRX
  • GE HEALTHCARE
  • JOHNSON & JOHNSON
  • KARDIUM
  • LIFETECH SCIENTIFIC CORP.
  • LUXCATH
  • MEDTRONIC
  • MICROPORT SCIENTIFIC CORP.
  • PHILIPS HEALTHCARE
  • SENTREHEART
  • STEREOTAXIS

第9章 付録

図表

List of Tables

  • Summary Table: Global Market for Atrial Fibrillation Devices, by Type, Through 2023
    • Table 1: Breakdown of U.S. Cost Burden of Cardiovascular Disease, 2015 and 2035
    • Table 2: Breakdown of U.S. Cost Burden of Cardiovascular Diseases, by Type 2015 and 2035
    • Table 3: Complications of Catheter Ablations and Incidence Rates, 2016
    • Table 4: Cardiology Workforce Demand and Supply Trends, by Cardiac Subspecialty, 2009
    • Table 5: Catheter Ablation and Left Atrial Appendage Closure Device Approvals, 2015-2018
    • Table 6: Global Market for Atrial Fibrillation Devices, by Major Segment, Through 2023
    • Table 7: Global Market for Catheter Ablation Devices, by Region, Through 2023
    • Table 8: Global Market for Catheter Ablation Devices, by Type, Through 2023
    • Table 9: Global Market for Electrophysiology Ablation Catheters, by Region, Through 2023
    • Table 10: Global Market for Electrophysiology Diagnostic Catheters, by Region, Through 2023
    • Table 11: Global Market for Lab Systems, by Region, Through 2023
    • Table 12: Global Market for Access Devices, by Region, Through 2023
    • Table 13: Cost Benefit Analysis of Left Atrial Appendage Closure vs. Anticoagulant Drugs
    • Table 14: Global Market for Left Atrial Appendage Closure Devices, by Region, Through 2023
    • Table 15: Global Market for Left Atrial Appendage Closure Devices, by Type, Through 2023
    • Table 16: Global Market for Endocardial Left Atrial Appendage Closure Devices, by Region, Through 2023
    • Table 17: Global Market for Epicardial Left Atrial Appendage Closure Devices, by Region, Through 2023
    • Table 18: Global Market for Atrial Fibrillation Devices, by Region, Through 2023
    • Table 19: North American Market for Atrial Fibrillation Devices, by Country, Through 2023
    • Table 20: European Market for Atrial Fibrillation Devices, by Country, Through 2023
    • Table 21: Asia-Pacific Market for Atrial Fibrillation Devices, by Country, Through 2023
    • Table 22: Product Portfolio Analysis
    • Table 23: Catheter Ablation Devices Market: Company Portfolio Comparison
    • Table 24: Left Atrial Appendage Closure Devices Market: Company Portfolio Comparison
    • Table 25: Key Industry Events in the Atrial Fibrillation Device Market, January 2015-July 2018
    • Table 26: Abbott Laboratories: Net Revenue, 2015-2017
    • Table 27: Abbott Laboratories: Products
    • Table 28: AtriCure: Net Revenue, 2015-2017
    • Table 29: AtriCure: Products
    • Table 30: Boston Scientific: Net Revenue, 2015-2017
    • Table 31: Boston Scientific: Products
    • Table 32: Johnson & Johnson: Net Revenue, 2015-2017
    • Table 33: Johnson & Johnson (Biosense Webster): Products and Services
    • Table 34: Medtronic: Net Revenue, 2015-2017
    • Table 35: Medtronic: Products
    • Table 36: MicroPort: Net Revenue, 2015-2017
    • Table 37: Sterotaxis: Net Revenue, 2015-2017
    • Table 38: Acronyms Used in Atrial Fibrillation

List of Figures

  • Summary Figure: Global Market for Atrial Fibrillation Devices, by Type, 2016-2023
    • Figure 1: Prevalence Rates of Atrial Fibrillation in Developed and Developing Countries, by Gender, 2010
    • Figure 2: Incidence Rates of Atrial Fibrillation in Developed and Developing Countries, by Gender, 2010
    • Figure 3: Trends in Inpatient Stays of Atrial Fibrillation Affected Patients, by Age Group, 2014
    • Figure 4: Atrial Fibrillation Market Dynamics
    • Figure 5: Trends in World Aging Population, 2017 and 2050
    • Figure 6: AFib Population Trends for the U.S. and Europe, 2010 and 2050
    • Figure 7: Global Market for Atrial Fibrillation Devices, by Major Segment, 2016-2023
    • Figure 8: Global Market Share for Atrial Fibrillation Devices, by Major Segment, 2017
    • Figure 9: Global Market Share for Atrial Fibrillation Devices, by Major Segment, 2023
    • Figure 10: Global Market for Catheter Ablation Devices, 2016-2023
    • Figure 11: Global Market for Catheter Ablation Devices, by Region, 2016-2023
    • Figure 12: Global Market Share for Catheter Ablation Devices, by Region, 2017
    • Figure 13: Global Market Share for Catheter Ablation Devices, by Region, 2023
    • Figure 14: Global Market for Catheter Ablation Devices, by Type, 2016-2023
    • Figure 15: Global Market Share for Catheter Ablation Devices, by Type, 2017
    • Figure 16: Global Market Share for Catheter Ablation Devices, by Type, 2023
    • Figure 17: Global Market for Electrophysiology Ablation Catheters, 2016-2023
    • Figure 18: Global Market for Electrophysiology Ablation Catheters, by Region, Through 2023
    • Figure 19: Global Market Share for Electrophysiology Ablation Catheters, by Region, 2017
    • Figure 20: Global Market Share for Electrophysiology Ablation Catheters, by Region, 2023
    • Figure 21: Global Market for Electrophysiology Diagnostic Catheters, 2016-2023
    • Figure 22: Global Market for Electrophysiology Diagnostic Catheters, by Region, 2016-2023
    • Figure 23: Global Market Share for Electrophysiology Diagnostic Catheters, by Region, 2017
    • Figure 24: Global Market Share for Electrophysiology Diagnostic Catheters, by Region, 2023
    • Figure 25: Global Market for Lab Systems, 2016-2023
    • Figure 26: Global Market for Lab Systems, by Region, 2016-2023
    • Figure 27: Global Market Share for Lab Systems, by Region, 2017
    • Figure 28: Global Market Share for Lab Systems, by Region, 2023
    • Figure 29: Global Market for Access Devices, 2016-2023
    • Figure 30: Global Market for Access Devices, by Region, 2016-2023
    • Figure 31: Global Market for Left Atrial Appendage Closure Devices, 2016-2023
    • Figure 32: Global Market for Left Atrial Appendage Closure Devices, by Region, 2016-2023
    • Figure 33: Global Market Share for Left Atrial Appendage Closure Devices, by Region, 2017
    • Figure 34: Global Market Share for Left Atrial Appendage Closure Devices, by Region, 2023
    • Figure 35: Global Market for Left Atrial Appendage Closure Devices, by Type, 2016-2023
    • Figure 36: Global Market Share for Left Atrial Appendage Closure Devices, by Type, 2017
    • Figure 37: Global Market Share for Left Atrial Appendage Closure Devices, by Type, 2023
    • Figure 38: Global Market for Endocardial Left Atrial Appendage Closure Devices, 2016-2023
    • Figure 39: Global Market for Endocardial Left Atrial Appendage Closure Devices, by Region, 2016-2023
    • Figure 40: Global Market Share for Endocardial Left Atrial Appendage Closure Devices, by Region, 2017
    • Figure 41: Global Market Share for Endocardial Left Atrial Appendage Closure Devices, by Region, 2023
    • Figure 42: Global Market for Epicardial Left Atrial Appendage Closure Devices, 2016-2023
    • Figure 43: Global Market for Epicardial Left Atrial Appendage Closure Devices, by Region, 2016-2023
    • Figure 44: Global Market Share for Epicardial Left Atrial Appendage Closure Devices, by Region, 2017
    • Figure 45: Global Market Share for Epicardial Left Atrial Appendage Closure Devices, by Region, 2023
    • Figure 46: North American Market for Atrial Fibrillation Devices, 2016-2023
    • Figure 47: European Market for Atrial Fibrillation Devices, 2016-2023
    • Figure 48: Asia-Pacific Market for Atrial Fibrillation Devices, 2016-2023
    • Figure 49: RoW Market for Atrial Fibrillation Devices, 2016-2023
    • Figure 50: Global Market Share for Atrial Fibrillation Devices, by Company, 2017
    • Figure 51: Global Market Share for Catheter Ablation Devices, by Company, 2017
    • Figure 52: Global Market Share for Atrial Appendage Closure Devices, by Company, 2017
    • Figure 53: Abbott Laboratories: Revenue, by Business Segment, 2015-2017
    • Figure 54: Abbott Laboratories: Revenue, by Country, 2015-2017
    • Figure 55: Abbott Laboratories: Revenue Share, by Cardiology Segment, 2015-2017
    • Figure 56: AtriCure: Revenue, by Product Segment, 2015-2017
    • Figure 57: AtriCure: Revenue Share, by Region/Country, 2017
    • Figure 58: Boston Scientific: Revenue, by Business Segment, 2015-2017
    • Figure 59: Boston Scientific: Revenue Share, by Business Segment, 2017
    • Figure 60: GE Healthcare: Annual Revenue, 2015-2017
    • Figure 61: GE Healthcare: Revenue Share, by Region, 2017
    • Figure 62: GE Healthcare: Revenue Share, by Product Division, 2017
    • Figure 63: Johnson & Johnson: Revenue Share, by Business Segment, 2017
    • Figure 64: Johnson & Johnson: Revenue Share, by Medical Device Segment, 2017
    • Figure 65: Medtronic: Revenue, by Business Segment, 2015-2017
    • Figure 66: Medtronic: Revenue Share, by Business Segment, 2017
    • Figure 67: Philips Sales Revenue, 2015-2017
    • Figure 68: Philips Sales Revenue Share, by Business Unit, 2016
    • Figure 69: Philips Sales Revenue Share, by Business Unit, 2017
    • Figure 70: Stereotaxis: Revenue, by Business Segment, 2015-2017
目次
Product Code: HLC198A

Report Highlights:

The global market for atrial fibrillation devices should grow from $4.1 billion in 2018 to $7.8 billion by 2023 at a compound annual growth rate (CAGR) of 13.6% for the period of 2018-2023.

Catheter ablation devices market for atrial fibrillation devices should grow from $3.9 billion in 2018 to reach $7.0 billion by 2023 at a CAGR of 12.6% for the period of 2018-2023.

Left atrial appendage closure devices market for atrial fibrillation devices should grow from $270.2 million in 2018 to reach $811.3 million by 2023 at a CAGR of 24.6% for the period of 2018-2023.

Report Scope:

The report on Atrial Fibrillation: Technologies and Global Markets covers interventional procedural products, namely Cardiac Ablation products and Left Atrial Appendage closure devices.

Devices included as a part of market estimates are:

  • Catheter ablation products, including electrophysiology ablation catheters, electrophysiology diagnostic catheters, lab systems (3D electro-anatomical mapping systems, robotic catheter navigation systems, intracardiac echocardiography systems, recording systems, ablation generators and irrigation pumps), access devices and consumables.
  • Left atrial appendage closure devices, including all occlusion device systems and implantable devices employed in endocardial and epicardial LAA procedures, which include cardiac plugs, clips and suture delivery systems.

Devices excluded from market estimates are:

  • Pharmacological drugs employed in standalone and combination of ablation procedures.
  • Devices like defibrillators and preliminary diagnostic devices, including cardiac monitors and Holter monitors (including implantable Holter monitors).
  • ECG machines and consumables, wearable devices, implantable loop recorders (ILR), pacemakers, and electrical cardioversion devices.
  • Further surgical ablation products employed in Cox-Maze IV or Mini-Maze surgery and thoracoscopy visualization devices.
  • Imaging systems such as Rotational angiography, fluoroscopy X-ray systems, CT and MRI imaging systems.

The report covers the market dynamics and trends that are shaping the atrial fibrillation treatment interventions. Other subjects discussed in the report are key qualitative factors like epidemiology, categories of atrial fibrillation, key device development and regulations.

The market landscape of atrial fibrillation was studied at a regional level covering North America, Europe, Asia-Pacific and Other markets. Profiles of key leading companies engaged in the marketing and development of atrial fibrillation devices are covered, with additional information on the market position of major companies in the atrial fibrillation market.

Report Includes:

  • 25 data tables and 13 additional tables
  • An overview of the global market for atrial fibrillation and technologies
  • Analyses of global market trends, with data from 2017, estimates for 2018, and projections of compound annual growth rates (CAGRs) through 2023
  • Detailed description of the market for drug treatment, surgical intervention, and other aspects of atrial fibrillation
  • Discussion of the types of atrial fibrillation treatment
  • A look into various government regulations
  • Insight into the emerging developmental technologies and clinical trials for new technology for atrial fibrillation
  • Company profiles of the manufacturers of surgical equipment, surgical accessories, and pharmaceuticals, including Abbott Laboratories, Aegis Medical Innovations, Boston Scientific, GE Healthcare, Johnson & Johnson, Medtronic and Philips Healthcare

Table of Contents

Chapter 1: Introduction

  • Study Goals and Objectives
  • Reasons for Doing this Study
  • Scope of Report
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2: Summary and Highlights

Chapter 3: Background

  • Heart Structure and Function
  • Cardiac Arrhythmia
    • Treadmill Run Test Stress Test
    • Holter Monitoring
    • Echocardiography
    • Electrophysiologic Testing
  • Atrial Fibrillation (AFib)
    • Symptoms
    • Global Epidemiology
    • Economic Burden of Atrial Fibrillation
    • Risk Factors
    • Complications of Atrial Fibrillation
    • Patterns of Atrial Fibrillation
  • Current Standard of Care for Atrial Fibrillation
    • Diagnosis
    • Treatment of AFib

Chapter 4: Market Overview

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Emerging Trends
  • Regulatory Landscape
    • Regulation in Europe
    • Regulation in the U.S.
    • Regulation in Japan
    • Regulation in China
    • Regulation in India

Chapter 5: Market Breakdown by Device Type

  • Introduction and Global Markets
  • Catheter Ablation Devices
    • Overview
    • Market Size and Forecast
    • Catheter Ablation Devices by Type
  • Left Atrial Appendage (LAA) Closure Devices
    • Overview
    • Cost Benefits of Left Atrial Appendage Closure Devices vs. Pharmacological Therapy
    • Market Size and Forecast
    • Types of Left Atrial Appendage Implantation

Chapter 6: Market Breakdown by Region

  • Introduction
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
  • Asia-Pacific
    • China
    • Japan
    • India
  • Rest of the World

Chapter 7: Competitive Landscape and Recent Developments

  • Market Share Analysis
    • Atrial Fibrillation: Company Market Share Analysis
    • Strategies Adopted by Market Leaders
    • Catheter Ablation Devices: Company Market Share Analysis
    • Left Atrial Appendage Closure Devices: Company Market Share Analysis
  • Barriers to the Entry for New Players
    • High Degree of Competitiveness
  • Product Portfolio Analysis
    • Catheter Ablation Devices Product Portfolio Analysis
    • Left Atrial Appendage Closure Devices Product Portfolio Analysis
  • Key Recent Industry Events

Chapter 8: Company Profiles

  • ABBOTT LABORATORIES
    • Company Overview
    • Financials
    • Atrial Fibrillation Business
    • Product Portfolio
    • Development and Strategies
  • ABLACOR MEDICAL CORP.
    • Company Overview
  • ACUTUS MEDICAL INC
    • Company Overview
  • AEGIS MEDICAL INNOVATIONS
    • Company Overview
  • AFREEZE GMBH
    • Company Overview
  • AURIS HEALTH (HANSEN MEDICAL)
    • Company Overview
  • ATRICURE INC
    • Company Overview
    • Financials
    • Business of Atrial Fibrillation
    • Product Portfolio
  • BIOTRONIK
    • Company Overview
  • BOSTON SCIENTIFIC
    • Company Overview
    • Financials
    • Product Portfolio
  • CARDIOFOCUS
    • Company Overview
  • CATHRX
    • Company Overview
  • GE HEALTHCARE
    • Company Overview
    • Financials
  • JOHNSON & JOHNSON
    • Company Overview
    • Financials
    • Business of Atrial Fibrillation
    • Product Portfolio
  • KARDIUM
    • Company Overview
  • LIFETECH SCIENTIFIC CORP.
    • Company Overview
  • LUXCATH
    • Company Overview
  • MEDTRONIC
    • Company Overview
    • Financials
    • Product Portfolio
  • MICROPORT SCIENTIFIC CORP.
    • Company Overview
    • Financials
  • PHILIPS HEALTHCARE
    • Company Overview
    • Financials
  • SENTREHEART
    • Company Overview
  • STEREOTAXIS
    • Company Overview

Chapter 9: Appendix: Acronyms

Back to Top